Biomarkers in angina

Scandinavian Journal of Clinical and Laboratory Investigation, Supplement

Volumn 65, Issue 240, 2005, Pages 86-92

  Collinson, Paul O ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; GELATINASE A; GELATINASE B; INTERCELLULAR ADHESION MOLECULE 1; NEOPTERIN; VASCULAR CELL ADHESION MOLECULE 1; LOW DENSITY LIPOPROTEIN; AUTACOID;

ADULT; ANGINA PECTORIS; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; CONFERENCE PAPER; DISEASE COURSE; EARLY DIAGNOSIS; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART PERFORMANCE; HUMAN; INFLAMMATION; MALE; MORTALITY; NEUROENDOCRINE SYSTEM; PRIORITY JOURNAL; RISK FACTOR; SYMPTOMATOLOGY; THROMBOSIS; ARTICLE; BLOOD; ATHEROSCLEROSIS; ATHEROTHROMBOTIC DISEASE; CARDIOVASCULAR RISK; FEMALE; MAJOR CLINICAL STUDY; PERFORMANCE; PREDICTION; SYMPTOM;

ANGINA PECTORIS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; HUMANS; LIPOPROTEINS, LDL; MYOCARDIAL ISCHEMIA; NATRIURETIC PEPTIDE, BRAIN;

ANGINA;

EID: 23744436380     PISSN: 0085591X     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365510500236002     Document Type: Conference Paper

References (31)

1. Collinson PO, Rao AC, Canepa-Anson R, Joseph S. Impact of European Society of Cardiology/American College of Cardiology guidelines on diagnostic classification of patients with suspected acute coronary syndromes. Ann.Clin.Biochem. 2003;40:156-60.
2. Refsum H, Smith AD, Ueland PM, Nexo E, Clarke R, McPartlin J et al. Facts and recommendations about total homocysteine determinations: an expert opinion. Clin.Chem. 2004;50:3-32.
3. Walldius G, Jungner I, Holme I, Aastveit AH, Kolar W, Steiner E. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet 2001;358:2026-33.
4. Williams K, Sniderman AD, Sattar N, D'Agostino R, Jr., Wagenknecht LE, Haffner SM. Comparison of the associations of apolipoprotein B and low-density lipoprotein cholesterol with other cardiovascular risk factors in the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2003;108:2312-6.
5. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:937-52.
6. Rioufol G, Finet G, Ginon I, Andre-Fouet X, Rossi R, Vialle E et al. Multiple atherosclerotic plaque rupture in acute coronary syndrome: a three-vessel intravascular ultrasound study. Circulation 2002;106:804-8.
7. Hong MK, Mintz GS, Lee CW, Kim YH, Lee SW, Song JM et al. Comparison of coronary plaque rupture between stable angina and acute myocardial infarction: a three-vessel intravascular ultrasound study in 235 patients. Circulation 2004;110:928-33.
8. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N.Engl.J.Med. 2002;347:1557-65.
9. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003;107:363-9.
10. Rifai N, Ridker PM. High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease. Clin.Chem. 2001;47:403-11.
11. Koenig W, Lowel H, Baumert J, Meisinger C. C-reactive protein modulates risk prediction based on the Framingham Score: implications for future risk assessment: results from a large cohort study in southern Germany. Circulation 2004;109:1349-53.
12. Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N.Engl.J.Med. 2004;350:1495-504.
13. Ridker PM, Cannon CP, Morrow D, Rifai N, Rose LM, McCabe CH et al. C-reactive protein levels and outcomes after statin therapy. N.Engl.J.Med. 2005;352:20-8.
14. Zouridakis E, Avanzas P, Arroyo-Espliguero R, Fredericks S, Kaski JC. Markers of inflammation and rapid coronary artery disease progression in patients with stable angina pectoris. Circulation 2004;110:1747-53.
15. Hong MK, Mintz GS, Lee CW, Kim YH, Lee SW, Song JM et al. Comparison of coronary plaque rupture between stable angina and acute myocardial infarction: a three-vessel intravascular ultrasound study in 235 patients. Circulation 2004;110:928-33.
16. James SK, Lindahl B, Siegbahn A, Stridsberg M, Venge P, Armstrong P et al. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy. Circulation 2003;108:275-81.
17. Kragelund C, Gronning B, Kober L, Hildebrandt P, Steffensen R. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. N.Engl.J.Med. 2005;352:666-75.
18. Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial. Lancet 2002;359:1269-75.
19. Apple FS, Wu AH, Mair J, Ravkilde J, Panteghini M, Tate J et al. Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome. Clin.Chem. 2005;51:810-24.
20. Bar-Or D, Curtis G, Rao N, Bampos N, Lau E. Characterization of the Co(2+) and Ni(2+) binding amino-acid residues of the N-terminus of human albumin. An insight into the mechanism of a new assay for myocardial ischemia. Eur.J.Biochem. 2001;268:42-7.
21. Laussac JP, Sarkar B. Characterization of the copper(II)- and nickel(II)-transport site of human serum albumin. Studies of copper(II) and nickel(II) binding to peptide 1-24 of human serum albumin by 13C and 1H NMR spectroscopy. Biochemistry 1984;23:2832-8.
22. Chevion M, Jiang Y, Har-El R, Berenshtein E, Uretzky G, Kitrossky N. Copper and iron are mobilized following myocardial ischemia: possible predictive criteria for tissue injury. Proc.Natl.Acad.Sci.U.S.A 1993;90:1102-6.
23. Sinha MK, Gaze DC, Tippins JR, Collinson PO, Kaski JC. Ischemia modified albumin is a sensitive marker of myocardial ischemia after percutaneous coronary intervention. Circulation 2003;107:2403-5.
24. Garrido IP, Roy D, Calvino R, Vazquez-Rodriguez JM, Aldama G, Cosin-Sales J et al. Comparison of ischemia-modified albumin levels in patients undergoing percutaneous coronary intervention for unstable angina pectoris with versus without coronary collaterals. Am.J.Cardiol. 2004;93:88-90.
25. Quiles J, Roy D, Gaze D, Garrido IP, Avanzas P, Sinha M et al. Relation of ischemia-modified albumin (IMA) levels following elective angioplasty for stable angina pectoris to duration of balloon-induced myocardial ischemia. Am.J.Cardiol. 2003;92:322-4.
26. Roy D, Quiles J, Sinha M, Aldama G, Gaze D, Kaski JC. Effect of direct-current cardioversion on ischemia-modified albumin levels in patients with atrial fibrillation. Am.J.Cardiol. 2004;93:366-8.
27. Christenson RH, Duh SH, Sanhai WR, Wu AH, Holtman V, Painter P et al. Characteristics of an Albumin Cobalt Binding Test for assessment of acute coronary syndrome patients: a multicenter study. Clin.Chem. 2001;47:464-70.
28. Bhagavan NV, Lai EM, Rios PA, Yang J, Ortega-Lopez AM, Shinoda H et al. Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction. Clin.Chem. 2003;49:581-5.
29. Roy D, Quiles J, Aldama G, Sinha M, Avanzas P, Arroyo-Espliguero R et al. Ischemia Modified Albumin for the assessment of patients presenting to the emergency department with acute chest pain but normal or non-diagnostic 12-lead electrocardiograms and negative cardiac troponin T. Int.J.Cardiol. 2004;97:297-301.
30. Sinha MK, Roy D, Gaze DC, Collinson PO, Kaski JC. Role of "Ischemia Modified Albumin", a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes. Emerg.Med.J. 2004;21:29-34.
31. Bassan R, Potsch A, Maisel A, Tura B, Villacorta H, Nogueira MV et al. B-type natriuretic peptide: a novel early blood marker of acute myocardial infarction in patients with chest pain and no ST-segment elevation. Eur.Heart J. 2005;26:234-40.